Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

News   Jan 23, 2018 | Original story from ICR

 
Could New Treatment Strategy Overcome Drug Resistance in Testicular Cancer?

Micrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Source: Wikimedia Commons CC BY SA 4.0

 
 
 

RELATED ARTICLES

Calidi Biotherapeutics, Inc. Announces its Corporate Vision in Groundbreaking Cancer Drug Development

News

Calidi Biotherapeutics, Inc., formerly StemImmune, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, announced a focused effort to advance its oncolytic virus drug development.

READ MORE

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

News

New programs added in respiratory and cardio-metabolic diseases.

READ MORE

Protein Acts as Brake on Learning and Memory

News

Researchers have discovered a new way that the protein RGS14 functions as a molecular brake on learning and memory

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy